Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 97: 527-534, 2004. First published April 23, 2004; doi:10.1152/japplphysiol.01347.2003
8750-7587/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
97/2/527    most recent
01347.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Bonen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Bonen, A.

Relationship between skeletal muscle MCT1 and accumulated exercise during voluntary wheel running

Yuko Yoshida,1 Hideo Hatta,1 Mai Kato,1 Taisuke Enoki,1 Hiroyuki Kato,1 and Arend Bonen2

1Department of Sports Sciences, University of Tokyo, Meguro-ku, Tokyo 153-8902, Japan; and 2Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G 2W1

Submitted 16 December 2003 ; accepted in final form 13 April 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We examined whether the quantity of exercise performed influences the expression of monocarboxylate transporter (MCT) 1 and MCT4 in mouse skeletal muscles (plantaris, tibialis anterior, soleus) and heart. Wheel running exercise (1, 3, and 6 wk) was used, which results in marked variations in self-selected running activity. Differences in muscle MCT1 and MCT4 among animals, before the initiation of running, were not related to the quantity of exercise performed on the first day of wheel running. No changes in MCT4 were observed over the course of the study (P > 0.05). After 6 wk of running, were there significant increases in heart (50%; P < 0.05) and muscle MCT1 (31–60%; P < 0.05) but not after 1 and 3 wk (P > 0.05). Because skeletal muscle MCT1 and running distances varied considerably, we examined the relationship between these two parameters. Within the first week of training, MCT1 was negatively correlated with the accumulated running distance (r = –0.70, P < 0.05). On further analysis, it appears that, in the first week, excessive running (>20 km/wk) represses MCT1 (–16.1%; P < 0.05), whereas more modest amounts of running (<20 km/wk) increase MCT1 (+37%; P < 0.05). After 3 wk of running, a positive relationship was observed between MCT1 and running distance (r = +0.76), although there is a threshold that must be exceeded before an increase over the control animals occurs. Finally, in week 6, when MCT1 was increased in the tibialis anterior and plantaris muscles, there were no correlations with the accumulated running distances. These studies have shown that mild exercise training fails to increase MCT4 and that changes in MCT1 are complex, depending not only the accumulated exercise but also on the stage of training.

lactate; plantaris; soleus; tibialis anterior; heart; distance; monocarboxylate transporter


LACTATE IS NOT ONLY AN END product of glycolysis but also an oxidizable substrate. This monocarboxylate is produced primarily in fast-twitch skeletal muscle fibers, and it is oxidized in the heart and in oxidative muscle fibers. The production-oxidation cycle of lactate requires exchange of this substrate between muscle fibers and other muscles (2, 5, 49), as well as other tissues, including heart (4, 27, 28), liver (8), kidney (18, 26, 44), and adipose tissue (20), where lactate can be metabolized. The extrusion of lactate from the muscle cell and its uptake by other muscle cells occur via a facilitated transport system involving monocarboxylate transport (MCT) proteins. It is now confirmed that there is a family of eight or more MCTs (21). MCT isoforms are expressed in a tissue-specific manner (2, 5, 1518, 20, 26, 28, 36, 3840, 42, 47, 49), and MCTs are also coexpressed within the same tissue (2, 4, 5, 16, 29, 42, 47, 49). These latter observations suggest that MCTs may have different roles and/or transport capacities. Indeed, it has been shown that MCT1, MCT2, and MCT4 exhibit very different transport capacities for lactate (6, 7, 11, 31, 33).

In skeletal muscle, MCT1 and MCT4 are coexpressed. Glycolytic muscle fibers express considerable quantities of MCT4, whereas MCT1 is predominantly present in oxidative muscle fibers in both slow- and fast-twitch muscles (2, 5, 12, 16, 36, 42, 47). It has been suggested that this MCT distribution among different types of muscle fibers may indicate that MCT1 is primarily involved with taking lactate up into the myocyte, whereas MCT4 may be primarily involved with extruding lactate (2, 5, 33). A number of studies have shown that training (1, 3, 12, 41) and chronically increased muscle contraction (5, 37) can increase MCT1 and MCT4 protein expression, as well as increase lactate transport (3, 5, 35, 37). Along with the suggestion that MCT1 and MCT4 have different roles, it also appears that MCT1 and MCT4 are regulated independently as animals age (22) and by the hormone 3,5,3'-triiodothyronine (48). Some studies also indicate that the expression of MCT1 and MCT4 is regulated differently by contractile activity. For example, an increase in MCT1 was only observed when exercise intensity exceeded a threshold (1), and with more intense aerobic exercise the increments in MCT1 were greater than in MCT4 (12, 41). Thus, although exercise intensity appears to be a factor regulating MCT1 and MCT4 expression, in chronic muscle stimulation studies it appeared that MCT1 expression was increased in relation to the amount of contractile activity that had been performed (5).

Whether the quantity of exercise can influence the expression of MCT1 and MCT4 has not been examined. However, this can be examined using voluntary wheel running, which is a low-intensity model of exercise that can induce adaptations similar to that found after low-intensity endurance training (14, 25, 43). Although there is considerable interanimal variation in the amount of self-selected running activity (14, 25, 32, 43), this variation, however, provides an opportunity to determine whether differences in the amount of running are related to the overexpression of MCTs. Because it appears that MCT1 overexpression is more easily induced than that of MCT4 (5, 41), we hypothesized that, with low-intensity wheel running, MCT1 would be upregulated, whereas MCT4 would not be altered. Therefore, we compared the changes in MCT1 and MCT4 in relation to the amount of exercise performed after 1, 3, and 6 wk of voluntary wheel running. For these purposes, we examined the heart and selected hindlimb muscles to discern whether there were specific responses in muscles with differing fiber composition.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Animals

Male ICR mice (Clea Japan, Tokyo, Japan), 4 wk of age, were used. Food (Oriental Yeast, Tokyo, Japan) and water were provided ad libitum. The room temperature was maintained at 23 ± 1°C with a 12-h light (2100 to 0900) and 12-h dark (0900 to 2100) cycle. All mice were weighed each week at the same time of day. Ethical approval for this work was obtained from the Committee on Animal Care at the University of Tokyo.

Training

Mice were randomly divided into control group or voluntary running wheel group for 1, 3, or 6 wk. Wheel running mice were housed individually in a cage (22 x 9 x 8 cm) with a running wheel (0.2-m diameter; Clea Japan). Mice ran freely in the wheel. The numbers of wheel revolutions were counted regardless of the running direction of the mice. Running distance was determined daily from the number of daily revolutions. Control group mice were housed with three per cage and did not have access to a running wheel.

Standardized Exercise Test

After 1, 3, or 6 wk of training, all mice performed a brief, standardized bout of exercise. Before this treadmill exercise, all mice had been familiarized with treadmill exercise by having run on the treadmill for 3–5 min on two to three occasions. The standardized exercise bout consisted of short-duration, intense treadmill running (i.e., 2 min of warming up at 20 m/min, 2 min of rest, and 2 min of running at 40 m/min). Immediately after the exercise, mice were killed by cervical dislocation. Within 5 min, all blood and tissue samples were obtained; specifically, the chest cavity was opened and blood was obtained via cardiac puncture, followed immediately by the removal of the heart and selected lower limb hindlimb muscles [soleus (Sol), plantaris (Pl), and tibialis anterior (TA)]. Tissues were frozen in liquid nitrogen and stored at –80°C until analyzed for MCT1 and MCT4 content. Concentrations of circulating lactate were determined enzymatically (19).

To examine the influence of MCT1 and MCT4 content on running performance, one group of animals ran in the running wheel for only 1 day. They did not perform the standardized exercise test, but instead they were killed by cervical dislocation at the end of the dark-light cycle, when they had completed most of their wheel running. Muscles (Pl, TA) were removed, frozen in liquid nitrogen, and stored at –80°C until analyzed for MCT1 and MCT4 content.

MCT Proteins

For the analysis of MCT, proteins were isolated from muscles as our laboratory has described previously (4, 5, 16, 36, 47, 48). MCTs were detected with Western blotting. Antibodies for MCT1 and MCT4 were raised in rabbits against the oligopeptide corresponding to the COOH terminus regions of each MCT (Qiagen, Tokyo, Japan). The procedures for the detection of MCT1 and MCT4 have been described in detail by our laboratory previously (4, 5, 16, 36, 47, 48). MCT1 and MCT4 blots were quantified using a scanner (model GT-8700, Epson, Tokyo, Japan) with appropriate software (NIH Image 1.62, National Institutes of Health, Bethesda, MD).

Statistical Analyses

All results are expressed relative to age-matched mice housed without access to a running wheel. Data are expressed as means ± SE. The group data were analyzed with analyses of variance. Significance was determined with Scheffé's F-test. Correlational analyses were used to compare the effects of running distance on MCT1. Significance was established at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Wheel Running Activity

There was a large increase in average daily running distance during the first half of the 6-wk experimental period. The running distance of the mice increased significantly from 3,014 ± 414 m/day (average of 7 days) during the first week to 4,013 ± 394 m/day (average of 7 days) in the third week (P < 0.05). Thereafter, the average daily running had reached a plateau during the next 3 wk. In week 6, the animals ran 4,207 ± 1,022 m/day (average of 7 days), which did not differ from the average daily running in week 3 (P > 0.05). At the end of weeks 1, 3, and 6, mice had run total distances of 21.1 ± 2.9, 83.6 ± 8.3 and 176.7 ± 42.9 km, respectively. However, there were large variations in the amount of the accumulated running distances among the mice over the 6-wk period (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Accumulated running distance after 1, 3, and 6 wk of voluntary wheel running

 
Body and Muscle Weights and Postexercise Blood Lactate

Body weights were significantly lower in the wheel running group (P < 0.05) (Fig. 1). Except for the Sol muscle in week 3, no significant differences in the weights of the sampled muscles (mg muscle/g body wt) were found (Table 2).



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1. Body weight in control mice (n = 9) and wheel running mice (n = 7) during the 6-wk period. Values are means ± SE. Body weights were significantly lower in wheel running mice from week 1 onward, P < 0.05.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Skeletal muscle weight relative to body weight in control and wheel running mice

 
Immediately after the 2-min, high-intensity standardized treadmill exercise, the blood lactate concentration in the wheel running group was lower than in the control group in each of the weeks (week 1: control 12.5 ± 1.3 mmol/l vs. running group 6.0 ± 0.9 mmol/l, P < 0.05; week 3: control 14.2 ± 1.0 mmol/l vs. running group 9.9 ± 1.3 mmol/l, P < 0.05; week 6: control 13.1 ± 1.5 mmol/l vs. running group 7.4 ± 2.3 mmol/l, P < 0.05). In the running group, the reduced postexercise blood lactate was not altered over the 6-wk period.

MCT1 and MCT4 proteins

Compared with the control groups at weeks 1 and 3, no changes in MCT1 protein were observed after 1 and 3 wk of running (P > 0.05; Fig. 2). Significant increases were observed in MCT1 after 6 wk of running in heart (+50%), Pl muscle (+31%), and TA muscle (+60%), compared with the 6-wk control group (P < 0.05; Fig. 2). There was an unexpected reduction in MCT1 in the Sol after 6 wk of running, compared with the 6-wk control group (–20%; P < 0.05).



View larger version (40K):
[in this window]
[in a new window]
 
Fig. 2. Monocarboxylate transporter (MCT) 1 (A–D) and MCT4 (E and F) content in plantaris (A and E), tibialis anterior (B and F), soleus (C), and heart (D) in control and wheel running mice after 1, 3, and 6 wk of running. Values are means ± SE; n = 6–7 muscles for each week in control and running wheel groups. OD, optical density. *P < 0.05. **P < 0.01.

 
No changes in MCT4 were observed in Pl or TA muscles over the course of the 6-wk exercise period (Fig. 2; P > 0.05). This isoform was not measured in heart and Sol, because MCT4 is not expressed in the heart (4) and because MCT4 concentrations are very low or not detectable in the Sol muscle of mice (data not shown).

Relationship Between Running Distance and MCTs

Despite the fact that significant changes in MCT1 were not evident on a group basis until week 6, there were individual animal variations in MCT1 and the amount of running performed in the study. Therefore, MCT1 expression was compared with the amount of running completed after either 1 day or 1, 3, and 6 wk of voluntary wheel running.

Day 1 and week 1.   There was no relationship between the 1-day running distance and MCT1 protein in either the Pl or TA muscles, when examined individually or when data of the two muscles were combined (Fig. 3). However, after 1 wk, there was an inverse correlation (r = –0.70, P < 0.05) between running distance and MCT1 protein in the hindlimb muscles (Sol, Pl, TA) (Fig. 4). This inverse correlation was also evident in the individual muscles, Pl (r = –0.86, P < 0.01), Sol (r = –0.76, P = 0.06), and TA (r = –0.65, P = 0.11). No relationship was evident between heart MCT1 and running distance (r = –0.31, P > 0.05).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3. Relationship between MCT1 (A) and MCT4 (B) in plantaris and tibialis anterior muscles and self-selected running on day 1. Note, for both MCT1 and MCT4, plantaris and tibialis anterior muscles are plotted on the same graph; A: n = 13 for each muscle; B: n = 14 for each muscle.

 


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4. Relationship between accumulated running distance and MCT1 in hindlimb muscles after 1, 3, and 6 wk of wheel running (n = 6–7 animals each week). Data from plantaris, tibialis anterior, and soleus muscle are plotted for each week shown. In week 6, the MCT1 values in soleus muscle are all <100 and all values in plantaris and tibialis anterior are >100.

 
Week 3.   After 3 wk of running, there was a positive relationship between the MCT1 protein in the muscles (Sol, Pl, TA) and the accumulated running distance over the 3-wk period (Fig. 4). This relationship was also evident in the TA (r = +0.92, P = 0.05) and Pl (r = +0.97, P < 0.05), although not in the Sol (r = +0.12, P > 0.05). In the heart, there was no relationship between running distance and MCT1 (r = +0.37, P > 0.05).

Week 6.   There was a positive relationship between running distance and MCT1 in week 6 in the TA muscle (r = +0.72, P < 0.05), but this was not observed in the other two muscles (Pl: r = +0.51, P = 0.24; Sol: r = +0.57, P = 0.13). Therefore, there was no relationship when the data from the muscles were combined and correlated with accumulated running distance (r = +0.13, P > 0.05; Fig. 4). No relationship was observed between MCT1 in the heart and accumulated running distance (r = +0.30, P > 0.05).

MCT4.   MCT4 in Pl and TA muscles did not correlate with running distances in weeks 1 (r = –0.39), 3 (r = 0.49), and 6 (r = 0.28) (P > 0.05). In addition, there were no relationships between MCT1 and MCT4 in the same muscles in any of the weeks.


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
In the present study, we observed that voluntary wheel running increased MCT1 in selected muscles and in the heart, whereas no such changes were observed in MCT4 in selected skeletal muscles. The novel observations in the present study were the changes in MCT1. These changes were related to the total amount of running completed, but the relationships changed at selected times of training. There appeared to be an early disruptive phase (week 1), a transitional adaptive phase (week 3), and an adapted phase (week 6).

Group Adaptations to Wheel Running Exercise

The well-known reduction in postexercise blood lactate that occurs with endurance training was also observed in the present study. Similarly, the increase in MCT1 after 6 wk of exercise training parallels previous observations in training studies with rodents (1, 16) and humans (3, 12, 41). Although differential tissue responsiveness to exercise has been observed for MCT1, with heart MCT1 being more easily induced than muscle MCT1 (1), the group changes in MCT1 in the heart were comparable to those of the TA and greater than in the Pl after 6 wk. Although others have shown that MCT4 is also increased with training (12, 16, 41), it appears from a number of studies that MCT1 expression is more easily induced than MCT4 (5, 41). When muscle contraction is highly aerobic, such as occurs with chronic low-frequency muscle stimulation, then only an increase in MCT1 expression is observed, whereas MCT4 is not altered (5). Because previous studies have shown that wheel running represents a low-intensity type of exercise (25, 43), it is quite likely that the upregulation of only the MCT1, but not MCT4, in the present study reflects the low intensity of wheel running exercise.

Variations in Running and MCT1 in Muscle at Selected Periods of Wheel Running

Variations in wheel running.   It was evident from the data that considerable variation occurred in the running activities among animals, as well as in the MCT1 content in the muscles under investigation. It is well known that there are large differences in self-selected, wheel running activity among animals (14, 25). The running performances of the mice in our studies compare well with those of others (14, 25, 32, 45). The coefficient of variation (CV = 100·SE/mean) in running in our study (CV range 14–28% over the 6-wk period) is similar to those in other studies (CV range 10–21%) (14, 25). Moreover, the average running distance per day in our study is also comparable to that observed in voluntary wheel running for mice (14). We have no data on the quality of running activity that was performed, but it has been shown previously that the number of sustained 1-min running bouts is increased over an 8-wk period of wheel running (45). Others have shown that maximal oxygen uptake (32, 45) and mitochondrial enzymes (25) are modestly increased in mice after 8 wk of voluntary wheel running. Thus self-selected wheel running induces metabolic adaptations that are qualitatively similar to those observed with more intense, forced treadmill exercise training.

Variations in MCT1 responses to wheel running.   Some very unique and unanticipated results were observed in the present study. Despite the fact that no statistically significant differences in MCT1 expression were observed in the wheel running groups after 1 and 3 wk of exercise, there were nevertheless considerable variations in MCT1 in the muscles examined. This prompted us to compare the MCT1 concentrations in the muscles with the amount of wheel running completed after 1 day and 1, 3 and 6 wk. We opted to compare the MCT1 responses with the total running distance completed, because previously our laboratory (5) had observed a good relationship between the increase in MCT1 and the amount of contractile activity in chronically stimulated muscles. We established at the outset (i.e., day 1) that mice with a greater content of muscle MCT1 at the beginning of the exercise program (day 1) were not a priori predisposed to more running. Indeed, the mice in this group ran the same amount on the first day as the average daily running distance observed in the 1-wk group. We then determined whether the accumulated running distances, after 1, 3, and 6 wk, were related to the MCT1 responses in mouse muscles.

MCT Responses at Selected Weeks of Running

MCT1 responses after the first week of wheel running.   Because the mean MCT1 content did not differ between the control and wheel running animals (P > 0.05) after 1 wk of running, despite the fact that there was a significant negative correlation between running distance and MCT1, it was evident that some muscles were already increasing their MCT1 content, whereas others were reducing their MCT1 content. Importantly, these changes occurred in relation to the amount of exercise performed over the entire week (r = –0.70). Interestingly, the key changes occurred when animals had run >20 km or <20 km in the first week. In the animals that had run 18.3 ± 0.3 km, there was an increase in MCT1 compared with the control group (+37%; P < 0.05), whereas in those mice that had run considerably further (26.2 ± 0.7 km; P < 0.05), there was a reduction in MCT1 relative to the control group (–16.1 ± 7.9%; P < 0.05). Thus the quantity of running appeared to be a key predictive factor in the changes observed in MCT1, albeit not necessarily a positive factor if running exceeded 20 km in the first week.

We are not aware of any studies that have reported a negative dose-dependent response to exercise training within the first week. This is not surprising because most studies, unlike self-selected wheel running, control the amount of exercise performed. However, there is some evidence that metabolic adaptations are not necessarily positive within the first few days of increased muscle activity. For example, after 3 days of chronic stimulation it appears that GLUT4 is reduced by 50% in rat hindlimb muscle (50) and that citrate synthase activity is also reduced (~20%) after 2 days of chronic stimulation (46). Thus there is evidence that the expected adaptive responses are at times counterintuitive within the first week of increased muscle activity (present study and Refs. 46, 50).

Even with long-term muscle stimulation, metabolic responses are not necessarily positive. For example, with long-term chronic stimulation, our laboratory (4) has first observed an increase in MCT1 after 7 days in white TA muscle, followed by a decrease in MCT1 with prolonged stimulation (21 days). This also parallels time-dependent increases and reductions in some enzymes after prolonged, chronic muscle stimulation (10, 24, 34). Although the reasons for the transient changes in muscle metabolic adaptation in the first week are not known, it has been proposed that muscle remodeling, which accompanies prolonged (i.e., weeks) muscle contraction, may interfere, in an unknown manner, with maintaining the levels of some enzymes (9, 34) and perhaps MCT1 (4). Analogously, when exercise training is begun, some metabolic remodeling is also initiated, and in the very early phases (≤1 wk) some reductions in some, but not all, proteins may occur (46, 50). Whether muscle damage occurs with "excessive" wheel running exercise in the first week of training is not known, but such presumed damage could reduce MCT1. Eccentric exercise-induced muscle damage can within 2 days reduce the GLUT4 transcription rate, GLUT4 mRNA, and GLUT4 protein content in rat skeletal muscle (30). Clearly, the present study and others (46, 50) have shown that reductions in selected proteins can occur within the first week of training, whereas the present study and others (3) have also shown that an increase in protein expression (MCT1) can occur. It appears that for MCT1, if the metabolic insult (i.e., running distance) in this very early phase (week 1) is too great, MCT1 will be repressed, whereas when it is more modest MCT1 is increased.

MCT1 responses after 3 wk of wheel running.   As was observed after 1 wk, there were no mean differences in MCT1 content in muscles when the control and wheel running animals were compared. But, just as in the week 1 group, some animals increased muscle MCT1 with exercise, whereas others had a reduced muscle MCT1 content, relative to controls. In contrast to the relationship between running distance after the first week of running, there was a positive relationship between the accumulated running distance over 3 wk and the skeletal muscle MCT1 (r = 0.76). A threshold in MCT1 responses appeared to exist at ~100 km of accumulated running over the 3 wk period. This became more evident when the animals were subdivided into those that had run >100 km (152.5 ± 9.1 km in 3 wk) and those that had run <100 km (76.6 ± 5.9 km in 3 wk; P < 0.05). Compared with the control animals, there was an increase in MCT1 (+21 ± 8.5%; P < 0.05) in animals that had run further, whereas there was a reduction in MCT1 in the animals that had run less (–25 ± 7.5%; P < 0.05). Rodnick et al. (43) have shown that, in freely exercising rats, there can be marked differences with self-selected run distances, such that in their study there were three identifiable groups of runners: group 1, 2–5 km/day; group 2, 6–9 km/day; and group 3, 11 km/day. The greatest changes in oxidative capacity occurred in the animals that ran the most, because running intensity was similar among the groups (43). Mice that were genetically predisposed for running (~10 km/day), when compared with normally running mice (~5 km/day), showed a greater increase in muscle oxidative enzyme activity (25). Our data indicate that only when the exercise accumulation has exceeded a certain limit [i.e., running >100 km over 3 wk (7.3 km/day)] is there an increase in MCT1. We have no obvious explanation as to why MCT1 was reduced in some of the animals, despite having run 76.6 km (3.6 km/day) in 3 wk. Although in some studies no changes in enzyme activities occurred with wheel running (25, 43), none has observed a decrease relative to control animals. If exercise intensity had been insufficient, we would have expected no change in MCT1 relative to the control group; our laboratory (22) has shown previously that MCT1 expression is quite stable in mature rat muscle.

Despite the unusual observation in the week 3 group, it should be noted that the positive relationship between MCT1 and accumulated running after 3 wk reported in this study is robust. Recently, as part of other ongoing studies, the 3-wk wheel running study was repeated, and similar results were again observed. Indeed, the data from that study and the present study fell on the same regression line (data not shown). Thus it appears that the 3 wk MCT1 data are not an anomaly, although it is not clear why there is an MCT1 reduction in some animals.

MCT1 responses after 6 wk of wheel running.   After 6 wk, MCT1 was increased in all Pl and TA muscles compared with the control group, whereas there was an unexpected reduction in soleus MCT1 content, for which we have no obvious explanation. However, others (23) have also observed transient adaptive responses with wheel running. For example, there was an improved insulin-stimulated glucose uptake in soleus muscle after 1 wk of wheel running, but this effect was lost after 2 and 4 wk of wheel running (23).

After 6 wk of running, there was no correlation between running distance and MCT1 content, even when the Sol muscle data were removed. It would appear therefore that, in the Pl and TA muscles, the critical running distance required to upregulate MCT1 had been attained. Hence, any correlation between MCT1 and accumulated running distance was lost. This parallels observations in chronically stimulated muscles in which MCT1 was upregulated in proportion to ascertain the amount of contractile activity, but once a maximum had been attained no further increase in MCT1 occurred despite the maintenance of more muscle activity (5). Others have observed that, with exercise training, enzymatic adaptations plateau and further exercise only serves to maintain the increased enzyme activity (13). Thus it appears that, after 6 wk of wheel running, the full MCT1 adaptations had occurred for this mode of exercise, and therefore no relationship with accumulated running distance was observed.

Exercise Intensity

The model used in the present study is generally considered to be a low-intensity exercise model. This appeared to contribute to the lack of change in MCT4, because this protein is increased when exercise intensity is high (12, 41). A certain level of exercise intensity is also required to increase MCT1 (1). However, these observations are based on studies using controlled quantities of exercise within the experimental groups. It appears, based on the present study, that the quantity of exercise, when exercise intensity is low, is also important in increasing MCT1. These factors (exercise intensity and exercise quantity) are often inversely related. The relative importance of these factors for inducing MCT 1 or MCT4 expression is not known.

Summary

We have shown that voluntary wheel running can reduce blood lactate accumulation after a standardized bout of intense exercise and increase MCT1 expression after 6 wk. The self-selected, low-intensity wheel running failed to alter the MCT4 content of the muscles. There was no relationship between changes in MCT1 and MCT4 or between the MCTs and postexercise circulating lactate. Because of the variations in self-selected running, we were able to observe distinct phases in MCT1 responses at different points over the 6-wk training period. It appears that, within the first week of training, MCT1 is negatively correlated with the accumulated running distance. On further analysis, it appears that excessive running represses MCT1, whereas more modest amounts of running increase MCT1 in week 1. In the third week of running, a positive relationship is observed between MCT1 and running distance, although as after 1 wk there is a threshold that must be exceeded before an increase over the control animals occurs. Below this threshold, MCT1 is reduced. Finally, except for the Sol muscle, MCT1 was increased in the TA and Pl muscles after 6 wk of wheel running. The observed increases in MCT1 in week 6 were not correlated with running distances, suggesting that an optimal exercise-induced adaptation in MCT1 had occurred between 3 and 6 wk of running, beyond which MCT1 did not increase further.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Natural Sciences and Engineering Research Council of Canada; and the Canada Research Chair program.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
A. Bonen is a Canada Research Chair in Metabolism and Health.


    FOOTNOTES
 

Address for reprint requests and other correspondence: H. Hatta, Dept. of Life Sciences (Sports Sciences), University of Tokyo, Komaba 3-8-1, Meguro-ku, Tokyo 153-8902, Japan (E-mail: hatta{at}idaten.c.u-tokyo.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Baker SK, McCullagh KJA, and Bonen A. Training intensity-dependent and tissue-specific increases in lactate uptake and MCT1 in heart and muscle. J Appl Physiol 84: 987–994, 1998.
  2. Bonen A. Expression of lactate transporters (MCT1, MCT4) in heart and muscle. Eur J Appl Physiol 86: 6–11, 2001.
  3. Bonen A, McCullagh KJA, Putman CT, Hultman E, Jones NL, and Heigenhauser GJF. Short-term training increases human muscle MCT1 and femoral venous lactate in relation to muscle lactate. Am J Physiol Endocrinol Metab 274: E102–E107, 1998.
  4. Bonen A, Miskovic D, Tonouchi M, Lemieux K, Wilson MC, Marette A, and Halestrap AP. Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles. Am J Physiol Endocrinol Metab 278: E1067–E1077, 2000.
  5. Bonen A, Tonuchi M, Miskovic D, Heddle C, Heikkila JJ, and Halestrap AP. Isoform-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity. Am J Physiol Endocrinol Metab 279: E1131–E1138, 2000.
  6. Broer S, Broer A, Schneider HP, Stegen C, Halestrap AP, and Deitmer JW. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem J 341: 529–535, 1999.
  7. Broer S, Schneider HP, Broer A, Rahman B, Hamprecht B, and Deitmer JW. Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. Biochem J 333: 167–174, 1998.
  8. Brooks GA, Dubouchaud H, Brown M, Sicurello JP, and Butz CE. Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle. Proc Natl Acad Sci USA 96: 1129–1134, 1999.
  9. Brown WE, Salmmons S, and Whalen RG. The sequential replacement of myosin subunit isoforms during muscle type transformation induced by long term electrical stimulation. J Biol Chem 258: 14686–14692, 1983.
  10. Chi M, MY, Hintz CS, Henriksson J, Salmons S, Hellendahl RP, Park JL, Nemeth PM, and Lowry OH. Chronic stimulation of mammalian muscle: enzyme changes in individual fibers. Am J Physiol Cell Physiol 251: C633–C642, 1986.
  11. Dimmer KS, Friedrich B, Lang F, Deitmer JW, and Broer S. The low affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 350: 219–227, 2000.
  12. Dubouchaud H, Butterfield GE, Wolfel EE, Bergman BC, and Brooks GA. Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle. Am J Physiol Endocrinol Metab 278: E571–E579, 2000.
  13. Dudley G, Abraham WM, and Terjung RA. Influence of exercise intensity and duration on biochemical adaptations in skeletal muscle. J Appl Physiol 53: 844–850, 1982.
  14. Dumke CL, Rhodes JS, Garland T Jr, Maslowski E, Swallow JG, Wetter AC, and Cartee GD. Genetic selection of mice for high voluntary wheel running: effect on skeletal muscle glucose uptake. J Appl Physiol 91: 1289–1297, 2001.
  15. Enerson BE, Zhdankina O, Gerhart DZ, and Drewes RL. Monocarboxylic acid transporter 1 (MCT1) expression in developing rat brain (Abstract). FASEB J 12: A1032, 1998.
  16. Enoki T, Yoshida Y, Hatta H, and Bonen A. Exercise training alleviates MCT1 and MCT4 reductions in heart and skeletal muscles of STZ-induced diabetic rats. J Appl Physiol 94: 2433–2438, 2003.
  17. Garcia CK, Brown MS, Pathak RK, and Goldstein JL. cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J Biol Chem 270: 1843–1849, 1995.
  18. Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, and Drewes LR. Expression of the monocarboxylate transporter MCT2 by rat brain glia. Glia 22: 272–281, 1998.
  19. Gutmann I and Wahlefeld AW. L-(+)-Lactate determination with lactate dehydrogenase and NAD. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. New York: Academic, 1974, p. 1464–1468.
  20. Hajduch E, Heyes RR, Watt PW, and Hundal HS. Lactate transport in adipocytes: identification of monocarboxyate transporter 1 (MCT1) and its modulation during streptozotocin-induced diabetes. FEBS Lett 479: 89–92, 2000.
  21. Halestrap AP and Price NT. The proton-linked monocarboxylate transporter family: structure, function and regulation. Biochem J 343: 281–299, 1999.
  22. Hatta H, Tonouchi M, and Bonen A. Tissue-specific and isoform-specific changes in MCT1 and MCT4 in heart and soleus muscle during a 1-yr period. Am J Physiol Endocrinol Metab 281: E749–E756, 2001.
  23. Henriksen EJ and Halseth AE. Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats. J Appl Physiol 76: 1862–1867, 1994.
  24. Henriksson JM, Chi MY, Hintz S, Young DA, Kaiser KK, Salmons S, and Lowry OH. Chronic stimulation of mammalian muscle: changes in enzymes of six metabolic pathways. Am J Physiol Cell Physiol 251: C614–C632, 1986.
  25. Houle-Leroy P, Garland TJ, Swallow JG, and Guderley H. Effects of voluntary activity and genetic selection on muscle metabolic capacities in house mice Mus domesticus. J Appl Physiol 89: 1608–1616, 2000.
  26. Jackson VN, Price NT, and Halestrap AP. Cloning of the monocarboxylate transporter isoform MCT2 from rat testis provides evidence that the expression is species specific and may involve post-transcriptional regulation. Biochem J 324: 447–453, 1997.
  27. Johannsson E, Lunde PK, Heddle C, Sjaastad I, Thomas MJ, Bergersen LJ, Halestrap AP, Blackstad TW, Ottersen OP, and Sejersted OM. Upregulation of the cardiac monocarboxylate transporter MCT1 in a rat model of congestive heart failure. Circulation 104: 729–734, 2001.
  28. Johannsson E, Nagelhus EA, McCullagh KJA, Sejersted OM, Blackstad TW, Bonen A, and Ottersen OP. Cellular and subcellular expression of the monocarboxylate transporter MCT1 in rat heart. A high resolution immunogold analysis. Circ Res 80: 400–407, 1997.
  29. Koehler-Stec EM, Simpson IA, Vannucci SJ, Landschulz KT, and Landschulz WH. Monocarboxylate transporter expression in mouse brain. Am J Physiol Endocrinol Metab 275: E516–E524, 1998.
  30. Kristiansen S, Jones J, Handberg A, Dohm GL, and Richter EA. Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle. Am J Physiol Cell Physiol 272: C1734–C1738, 1997.
  31. Lin RY, Vera JC, Chaganti RS, and Golde DW. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem 273: 28959–28965, 1998.
  32. MacNeil B and Hoffman-Goetz L. Exercise training and tumor metastasis in in mice: influence of time and exercise onset. Anticancer Res 13: 1369–1374, 1993.
  33. Manning Fox JE, Meredith D, and Halestrap AP. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol 529: 285–293, 2000.
  34. Mayne CN, Sutherland H, Jarvis JC, Gilroy SJ, Craven AJ, and Salmons S. Induction of a fast-oxidative phenotype by chronic muscle stimulation: histochemical and metabolic studies. Am J Physiol Cell Physiol 270: C313–C320, 1996.
  35. McCullagh KJA, Juel C, O'Brien M, and Bonen A. Chronic muscle stimulation increases lactate transport in rat skeletal muscle. Mol Cell Biochem 156: 51–57, 1996.
  36. McCullagh KJA, Poole RC, Halestrap AP, O'Brien M, and Bonen A. Role of the lactate transporter (MCT1) in skeletal muscles. Am J Physiol Endocrinol Metab 271: E143–E150, 1996.
  37. McCullagh KJA, Poole RC, Halestrap AP, O'Brien M, and Bonen A. Chronic electrical stimulation increases MCT1 and lactate uptake in red and white skeletal muscle. Am J Physiol Endocrinol Metab 273: E239–E246, 1997.
  38. Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin JL, Stella N, and Magistretti PJ. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 20: 291–299, 1998.
  39. Pellerin L, Pellegri G, Martin JL, and Magistretti PJ. Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc Natl Acad Sci USA 95: 3990–3995, 1998.
  40. Philp NJ, Yoon H, and Grollman EF. Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am J Physiol Regul Integr Comp Physiol 274: R1824–R1828, 1998.
  41. Pilegaard H, Domino K, Noland T, Juel C, Hellsten Y, Halestrap AP, and Bangsbo J. Effect of high-intensity exercise training on lactate/H+ transport capacity in human skeletal muscle. Am J Physiol Endocrinol Metab 276: E255–E261, 1999.
  42. Pilegaard H, Terzis G, Halestrap A, and Juel C. Distribution of the lactate/H+ transporter isoforms MCT1 and MCT4 in human skeletal muscle. Am J Physiol Endocrinol Metab 276: E843–E848, 1999.
  43. Rodnick KJ, Reaven GM, Haskell WL, Sims CR, and Mondon CE. Variations in running activity and enzymatic adaptations in voluntary running rats. J Appl Physiol 66: 1250–1257, 1989.
  44. Schuster VL, Bao Y, Fritz PH, and Jennings ML. Immunological identification of basolateral lactate-H+ cotransporter in rabbit kidney (Abstract). J Am Soc Nephrol 2: 84, 1991.
  45. Swallow JG, Garland T Jr, Carter PA, Zhan WZ, and Sieck GC. Effects of voluntary activity and genetic selection on aerobic capacity in house mice (Mus domesticus). J Appl Physiol 84: 69–76, 1998.
  46. Takahashi M and Hood DA. Chronic stimulation-induced changes in mitochondria and performance in rat skeletal muscle. J Appl Physiol 74: 934–941, 1993.
  47. Tonouchi M, Hatta H, and Bonen A. Muscle contraction increases lactate transport while reducing sarcolemmal MCT4, but not MCT1. Am J Physiol Endocrinol Metab 282: E1062–E1069, 2002.
  48. Wang Y, Tonouchi M, Miskovic D, Hatta H, and Bonen A. T3 increases lactate transport and the expression of MCT4, but not MCT1, in rat skeletal muscle. Am J Physiol Endocrinol Metab 285: E622–E628, 2003.
  49. Wilson MC, Jackson VN, Hedle C, Price NT, Pilegaard H, Juel C, Bonen A, Montgomery I, Hutter OF, and Halestrap AP. Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter MCT3. J Biol Chem 273: 15920–15926, 1998.
  50. Yaskelpis EB III, Castle AL, Farrar RP, and Ivy JL. Contraction-induced intracellular signals and their relationship to muscle GLUT-4 concentration. Am J Physiol Endocrinol Metab 272: E118–E125, 1997.



This article has been cited by other articles:


Home page
J. Physiol.Home page
Y. Yoshida, G. P. Holloway, V. Ljubicic, H. Hatta, L. L. Spriet, D. A. Hood, and A. Bonen
Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white rat skeletal muscle
J. Physiol., August 1, 2007; 582(3): 1317 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Bishop, J. Edge, C. Thomas, and J. Mercier
High-intensity exercise acutely decreases the membrane content of MCT1 and MCT4 and buffer capacity in human skeletal muscle
J Appl Physiol, February 1, 2007; 102(2): 616 - 621.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Enoki, Y. Yoshida, J. Lally, H. Hatta, and A. Bonen
Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle
J. Physiol., November 15, 2006; 577(1): 433 - 443.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
97/2/527    most recent
01347.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Bonen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Bonen, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.